12 Health Care Stocks Moving In Friday's After-Market Session
Portfolio Pulse from Benzinga Insights
In Friday's after-market session, several healthcare stocks experienced significant movements. Ocean Biomedical (OCEA) led the gainers with a 37.6% increase, while Telesis Bio (TBIO) saw the largest decrease among the losers, dropping 14.5%. Other notable movers included NeuBase Therapeutics (NBSE), ZyVersa Therapeutics (ZVSA), and Celularity (CELU). These movements reflect the volatile nature of healthcare stocks in the market.
February 23, 2024 | 9:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Celularity's stock fell 13.66% to $0.4, with a market value of $86.7 million.
The decline in CELU's stock price could be due to negative investor sentiment or adverse company news, likely leading to short-term downward movement.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Telesis Bio's stock decreased by 14.5% to $0.67, with a market cap of $19.9 million.
The drop in Telesis Bio's stock price could reflect investor concerns or negative news related to the company, potentially leading to short-term downward pressure.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
NeuBase Therapeutics' shares rose 35.85% to $1.02, with a market value of $3.8 million.
The substantial increase in NBSE's stock price suggests positive investor sentiment or favorable company news, likely leading to short-term gains.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 100
POSITIVE IMPACT
Ocean Biomedical's stock rose 37.6% to $2.16, with a market cap of $73.6 million.
The significant rise in Ocean Biomedical's stock price indicates strong investor interest or positive developments within the company. This could lead to short-term upward momentum.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
ZyVersa Therapeutics' shares increased by 13.82% to $0.91, with a market cap of $4.2 million.
ZVSA's stock price rise indicates potential positive developments or investor optimism, suggesting a short-term positive trend.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 100